Expression of interleukin-1beta in human breast carcinoma.

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23

Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res (2007) 1.95

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res (2002) 1.90

Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem (2009) 1.67

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer (2011) 1.63

Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer (2006) 1.09

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One (2013) 1.07

Inflammasomes in cancer: a double-edged sword. Protein Cell (2014) 1.01

The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines. Cancer Microenviron (2011) 0.98

Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification. Carcinogenesis (2011) 0.98

Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis. Front Immunol (2014) 0.96

The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res (2014) 0.95

Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflamm Res (2009) 0.94

Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. Matrix Biol (2012) 0.92

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther (2015) 0.90

Hyaluronan, Inflammation, and Breast Cancer Progression. Front Immunol (2015) 0.87

Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures. Neoplasia (2013) 0.84

Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta Gene (2014) 0.81

Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol (2014) 0.81

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment. Oncotarget (2016) 0.80

Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines. J Nat Prod (2012) 0.80

Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients. Int J Clin Exp Pathol (2014) 0.79

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression. Nat Commun (2016) 0.79

The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells. BMC Cancer (2014) 0.79

Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression. Oncotarget (2015) 0.78

Bioactive secondary metabolites from acid mine waste extremophiles. Nat Prod Commun (2014) 0.78

Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br J Cancer (1999) 0.78

Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration. Oncol Lett (2016) 0.78

Prognostic significance of STAT3/phosphorylated-STAT3 in tumor: a meta-analysis of literatures. Int J Clin Exp Med (2015) 0.77

Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction. PLoS One (2015) 0.77

Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? Biomark Cancer (2015) 0.77

Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness. Int J Breast Cancer (2012) 0.77

Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol (2016) 0.76

Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. Br J Cancer (2001) 0.76

Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology (2016) 0.75

Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: a role for nuclear interleukin-1β. Cancer Biol Ther (2010) 0.75

CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomed Rep (2016) 0.75

Dibutyltin-induced alterations of interleukin 1beta secretion from human immune cells. J Appl Toxicol (2016) 0.75

Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. Mol Cancer (2017) 0.75

Targeting inflammasome/IL-1 pathways for cancer immunotherapy. Sci Rep (2016) 0.75

Tetrabromobisphenol A and hexabromocyclododecane alter secretion of IL-1β from human immune cells. J Immunotoxicol (2015) 0.75

Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development. Front Immunol (2017) 0.75

Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer (2017) 0.75

S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β. J Exp Med (2017) 0.75

Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro. Cancer Immunol Immunother (2017) 0.75

Isolation and characterization of adult mammary stem cells from breast cancer-adjacent tissues. Oncol Lett (2017) 0.75

Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages. Oncoimmunology (2017) 0.75

Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (1992) 7.92

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04

Biological action of leptin as an angiogenic factor. Science (1998) 6.02

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature (1987) 5.24

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem (1995) 4.77

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67

Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med (1997) 3.90

Activated macrophages induce vascular proliferation. Nature (1977) 3.74

Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (1996) 3.49

Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1996) 3.45

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr (1997) 3.40

The de facto US mental health services system: a public health perspective. Arch Gen Psychiatry (1978) 3.33

Mechanisms for discordant alternans. J Cardiovasc Electrophysiol (2001) 3.31

A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29

New world views: preparing physicians in training for global health work. Fam Med (2000) 3.23

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol (1999) 3.15

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol (1993) 3.15

Regenerative release of calcium from functionally discrete subcellular stores by inositol trisphosphate. Proc Biol Sci (1991) 3.14

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (1995) 3.07

Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol (1998) 3.05

Structural basis for the activation of 20S proteasomes by 11S regulators. Nature (2000) 3.04

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol (1995) 2.96

Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science (1995) 2.88

Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86

Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest (2001) 2.61

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res (1999) 2.55

BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science (1999) 2.54

Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol (1998) 2.53

HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53

Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med (1999) 2.45

Elementary events of InsP3-induced Ca2+ liberation in Xenopus oocytes: hot spots, puffs and blips. Cell Calcium (1996) 2.37

Incidence of Haemophilus influenzae type b meningitis in India. Indian J Med Res (2008) 2.31

Ca2+ transients associated with openings of inositol trisphosphate-gated channels in Xenopus oocytes. J Physiol (1996) 2.28

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell (1989) 2.27

The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest (1996) 2.24

The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest (1996) 2.20

Improving immunization coverage. World Health Forum (1988) 2.20

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med (1996) 2.14

Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11

Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol (1992) 2.08

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med (1994) 2.05

Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest (1984) 2.04

Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol (2005) 2.04

Superconductivity in hydrogen dominant materials: silane. Science (2008) 2.03

Direct bioautography on thin-layer chromatograms as a method for detecting fungitoxic substances. J Chromatogr (1970) 2.02

Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00

p53 antigen loss in stored paraffin slides. N Engl J Med (1995) 1.99

Cotransduction and cotransformation of genetic markers in Bacillus subtilis and Bacillus licheniformis. J Bacteriol (1969) 1.98

Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95

Type 2 diabetes in southern Kerala: variation in prevalence among geographic divisions within a region. Natl Med J India (2001) 1.94

MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene (2011) 1.94

Comparing the smoking behavior of veterans and nonveterans. Public Health Rep (1997) 1.92

Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res (2001) 1.92

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89

A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Med Care (1983) 1.87

Ten-year course of schizophrenia--the Madras longitudinal study. Acta Psychiatr Scand (1994) 1.85

Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene (2001) 1.82

[Morphometric study of the distribution of a specific cytoplasmatic organoid in the rat's endothelial cells]. Z Zellforsch Mikrosk Anat (1966) 1.81

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol (1999) 1.77

Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev (1997) 1.75

Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst (1994) 1.75

Impression cytology of the ocular surface. Br J Ophthalmol (2005) 1.74

Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med (2000) 1.73

Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73

Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum (1986) 1.71

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol (1990) 1.71

Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun (1995) 1.71

Counting knowledge and skill in cognitive addition: a comparison of normal and mathematically disabled children. J Exp Child Psychol (1992) 1.69

Endothelial proliferation in the delayed hypersensitivity reaction: an autoradiographic study. J Immunol (1977) 1.67

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet (1994) 1.66

Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res (1997) 1.66

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65

Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A (1994) 1.65

Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol (1999) 1.65

Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol (1995) 1.64

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol (1994) 1.64

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol (2001) 1.64

Are surgeons aware of the dangers of diathermy? Ann R Coll Surg Engl (2000) 1.63

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency. J Pediatr (1986) 1.59

Interspecies transformation between Bacillus subtilis and Bacillus licheniformis. Biochem Biophys Res Commun (1966) 1.57

A new classification of ocular surface burns. Br J Ophthalmol (2001) 1.56

Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ (1992) 1.56

Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Drug Metab Dispos (1999) 1.56

Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res (2000) 1.56

Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun (1988) 1.54

Papillary lesions of the breast: selected diagnostic and management issues. Histopathology (2008) 1.53

Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer (1996) 1.53

In vitro study of bacterial growth inhibition in concentrated sugar solutions: microbiological basis for the use of sugar in treating infected wounds. Antimicrob Agents Chemother (1983) 1.53

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer (1999) 1.52